RSV vaccines slash infections: data show jabs’ staggering success against dangerous virus

Data from Denmark indicates that a nationwide RSV vaccination program for pregnant people has significantly reduced hospitalizations among infants. The vaccine provides maternal antibodies that protect newborns during their most vulnerable months.
Why it matters
Demonstrates the public health efficacy of maternal immunization strategies in preventing severe respiratory disease in infants.
Liam Drew is a freelance science journalist based near London.
Search author on: PubMed Google Scholar
Bluesky Facebook LinkedIn Reddit Whatsapp X Save article View saved research Protection against the respiratory syncytial virus (RSV) must expand to lower-income countries, which are harder hit. Credit: Hailshadow/Getty
“Something’s wrong with the data. There are too few people in hospitals” with respiratory syncytial virus (RSV), epidemiologist Caroline Klint Johannesen recalls a colleague remarking while analysing Danish health records for last winter.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in